跳至主要内容
临床试验/KCT0002060
KCT0002060招募中未知

Efficacy, safety and dose finding trial of topical Jaungo application in atopic dermatitis patients: a randomized, double-blind, placebo-controlled study

Kyung Hee University Oriental Medicine Hospital at Gangdong0 个研究点目标入组 34 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
5(Year) 至 65(Year)(—)
性别
All

入选标准

  • 1) The diagnosis of AD will be made according to the criteria of Hanifin and Rajka
  • 2) Age: 5 years to 65 years
  • 3) objective SCORAD ?40, Diagnosis of Mild to Moderate Atopic Dermatitis (AD)
  • 4) Exoriation=1, Lichenification=1, Dryness=1 or Exoriation+Lichenification+Dryness=3
  • 5) Participants who able to express intention
  • 6) Participants willing to provide written informed consent

排除标准

  • 1) Participants have oozing in the lesion
  • 2) Users of following medications prior to trial periods
  • ? Oral steroids, immunosuppressants and antibiotics within 4 weeks prior to this trial
  • ? Topical steroids, immunosuppressants and antibiotics within 2 weeks prior to this trial
  • ? Light therapy within 2 weeks prior to this trial
  • ? Other medications thought to be inappropriate by researchers
  • 3) Participants have severe burn or wide wound
  • 4) Participants have oozing or ulcer in the lesion
  • 5) Allergic reactions to Angelica gigas, Siebold et Zuccarini, sesame oil and lard
  • 6) Participants have skin disease except atopic dermatitis
  • 7) Participants have severe renal function disease (sCr > 2.0 mg/dL)
  • 8) Participants have severe liver function disease (ALT, AST, ALP = 2.5 × normal limits)
  • 9) Participants have uncontrolled chronic diseases
  • 10) Pregnancy, lactation
  • 11) Participation in another clinical trial within one month of enrolment
  • 12) Underlying disease or history of severe disease, abnormal state (paralysis; mental retardation other emotional or mental problems; diseases that can affect the absorption of drugs; no enough time to participate in this trial; visual disturbance and hearing impairment; inability to understand written consent or engage in this study)
  • 13) Judgment by experts that the potential subject’s participation is inappropriate.

研究者

发起方
Kyung Hee University Oriental Medicine Hospital at Gangdong

相似试验